Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GAGE8 Inhibitors

GAGE8 inhibitors are a specialized class of chemical compounds that are designed to specifically target and inhibit the activity of the GAGE8 protein, which belongs to the GAGE (G antigen) family of proteins. These proteins are characterized by their involvement in various cellular functions, including interactions with other proteins and participation in signaling pathways. The precise biological role of GAGE8 is still under investigation, but it is known to be expressed in specific cellular contexts. Inhibitors of GAGE8 are typically small molecules that interact with the protein at critical sites, such as the active site or other regions necessary for its function. By binding to these sites, the inhibitors disrupt the normal activity of GAGE8, preventing it from carrying out its cellular roles. This inhibition can result from direct competition with natural substrates or from allosteric modulation that alters the protein's conformation.

The design and development of GAGE8 inhibitors involve a deep understanding of the protein's structural biology and the key molecular interactions that underlie its activity. Researchers often employ techniques such as high-throughput screening to identify potential inhibitory compounds, followed by detailed structure-activity relationship (SAR) studies to optimize their efficacy and selectivity. The chemical structures of GAGE8 inhibitors are diverse, often featuring specific functional groups that enable strong binding interactions with the protein. These interactions may include hydrogen bonds, hydrophobic contacts, and van der Waals forces that stabilize the inhibitor within the protein's binding pocket. Additionally, achieving selectivity for GAGE8 over other related proteins is a critical aspect of inhibitor design. This selectivity is typically achieved through careful molecular optimization, ensuring that the inhibitor fits precisely within the unique structural features of GAGE8. The resulting inhibitors are valuable tools for probing the biological functions of GAGE8, providing insights into its role in cellular processes and facilitating further biochemical studies.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Influences GAGE8 activity by modulating phosphorylation pathways crucial in cell cycle regulation and cancer progression.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Affects GAGE8 activity as a tyrosine kinase inhibitor, impacting signaling pathways in cancer cell proliferation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Alters the mTOR pathway, involved in cell growth, proliferation, and survival, thereby influencing GAGE8.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Impacts GAGE8 activity indirectly through DNA intercalation and inhibition of topoisomerase II, affecting cancer cell growth.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Modulates signaling pathways in cancer cells, particularly in leukemia, affecting GAGE8 activity.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Disrupts microtubule dynamics as a microtubule stabilizer, impacting GAGE8 indirectly and affecting cancer cell division.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

Disrupts RNA and DNA synthesis in cancer cells as a pyrimidine analog, influencing GAGE8.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Affects GAGE8 activity by disrupting protein degradation pathways, crucial in cancer cell survival and proliferation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Influences GAGE8 by targeting multiple kinases involved in cancer cell signaling, proliferation, and angiogenesis.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Impacts GAGE8 indirectly by causing DNA crosslinks, affecting cancer cell growth and triggering apoptosis.